178 related articles for article (PubMed ID: 36051501)
1. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation.
Lagreula J; de Timary P; Elens L; Dalleur O
Ther Adv Psychopharmacol; 2022; 12():20451253221112587. PubMed ID: 36051501
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.
Choi HJ; Jung SH; Kang MH; Lee JS; Bae JN; Kim CE
Clin Psychopharmacol Neurosci; 2011 Apr; 9(1):17-22. PubMed ID: 23430568
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study.
Patrichi B; Ţăpoi C; Rogojină RŞ; Bedreagă I; Dumitrache A; Itu A; Dragomir R; Buciuc AG
Exp Ther Med; 2021 Nov; 22(5):1225. PubMed ID: 34539821
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
Lin CH; Huang CJ; Lin TC; Chan HY; Chen JJ
Psychiatry Res; 2023 Dec; 330():115575. PubMed ID: 37913621
[TBL] [Abstract][Full Text] [Related]
6. Prescribing and deprescribing trends in schizophrenia: An overview of inpatients in Belgium and in the Canadian province of Québec.
Lagreula J; Dagenais-Beaulé V; de Timary P; Elens L; Dalleur O
Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):691-702. PubMed ID: 36988426
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
9. Patterns of antipsychotic prescriptions in patients with schizophrenia in China: A national survey.
Wang J; Jiang F; Zhang Y; Cotes RO; Yang Y; Liu Z; Ning X; Liu T; Liu Y; Tang YL; Liu H
Asian J Psychiatr; 2021 Aug; 62():102742. PubMed ID: 34243064
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study.
Joo SW; Kim H; Jo YT; Ahn S; Choi YJ; Choi W; Park S; Lee J
Eur Neuropsychopharmacol; 2022 Jun; 59():36-44. PubMed ID: 35550204
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.
Ayenew W; Asmamaw G; Bitew T
Int J Neuropsychopharmacol; 2021 Dec; 24(12):956-964. PubMed ID: 34245271
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.
Lee LHN; Procyshyn RM; White RF; Woodward TS; Honer WG; Barr AM
PLoS One; 2018; 13(8):e0199758. PubMed ID: 30096136
[TBL] [Abstract][Full Text] [Related]
14. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
[TBL] [Abstract][Full Text] [Related]
16. Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.
Ochi S; Tagata H; Hasegawa N; Yasui-Furukori N; Iga JI; Kashiwagi H; Kodaka F; Komatsu H; Tsuboi T; Tokutani A; Numata S; Ichihashi K; Onitsuka T; Muraoka H; Iida H; Ohi K; Atake K; Kishimoto T; Hori H; Takaesu Y; Takeshima M; Usami M; Makinodan M; Hashimoto N; Fujimoto M; Furihata R; Nagasawa T; Yamada H; Matsumoto J; Miura K; Kido M; Hishimoto A; Ueno SI; Watanabe K; Inada K; Hashimoto R
Int J Neuropsychopharmacol; 2022 Oct; 25(10):818-826. PubMed ID: 35723038
[TBL] [Abstract][Full Text] [Related]
17. Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study.
Sneider B; Pristed SG; Correll CU; Nielsen J
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1669-76. PubMed ID: 26256007
[TBL] [Abstract][Full Text] [Related]
18. Patterns of drug prescribing in inpatients with first episode of schizophrenia spectrum disorder: The role of guidelines
.
Stašević M; Stašević Karličić I; Grgurević A; Divac N
Int J Clin Pharmacol Ther; 2020 Jul; 58(7):387-394. PubMed ID: 32352369
[TBL] [Abstract][Full Text] [Related]
19. Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients.
Lassen S; Heintz T; Pedersen T; Jentz C; Nathanielsen N; Heilmann P; Sørensen LU
Int J Circumpolar Health; 2023 Dec; 82(1):2218654. PubMed ID: 37300837
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy: a needle in a haystack?
López de Torre A; Lertxundi U; Hernández R; Medrano J
Gen Hosp Psychiatry; 2012; 34(4):423-32. PubMed ID: 22460003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
